Working together towards better tools and solutions for tackling placental malaria
Partners in the ADVANCE VAC4PM project from Europe and sub-Saharan Africa came together in Nijmegen, the Netherlands, on 4-5 November 2026 for a face-to-face consortium meeting.

Alongside external experts, partners reviewed progress, shared knowledge and experience, addressed current challenges, and plan next steps. Discussions covered the mobile health app, the work of the project’s PhD students, the cost-effectiveness analysis and the feasibility/acceptability study of a placental malaria vaccine.
Preparations for the Phase Ia/Ib clinical trial with the PAMVAC-cVLP and PRIMVAC placental malaria vaccines, to be conducted in the Netherlands and Burkina Faso, were also a key focus. The meeting provided an opportunity to discuss the requirements for moving into the clinical phase, an important milestone for the project’s vaccine development work.
ADVANCE_VAC4PM aims to contribute to the development of a vaccine against placental malaria, strengthen research capacity in Sub-Saharan Africa, develop eHealth technologies and evaluate vaccine cost-benefit and acceptability for future implementation programmes.
The meeting also offered a valuable opportunity to strengthen collaboration between European and African partners and bring together expertise from different fields to advance the project's work.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
